# AC Immune (ACIU) — Earnings

ACIU · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/aciu/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q4 2025 |
| Period end | Dec 31, 2025 |
| EPS actual | −$0.18 |
| EPS estimate | −$0.21 |
| EPS surprise | +16.22% |
| Revenue surprise | −70.32% |
| Revenue | $428,876.00 |
| Revenue estimate | $1.4M |
| Reported | Mar 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1651625/000110465926027342/aciu-20251231x20f.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q4 2025 | Mar 13, 2026 | −$0.21 | −$0.18 | 16.22% | $1.4M | $428,876.00 |
| Q3 2025 | Nov 4, 2025 | −$0.23 | −$0.16 | 28.96% | $993,866.36 | $954,036.87 |
| Q2 2025 | Aug 5, 2025 | −$0.26 | −$0.26 | 0.00% | $1.6M | $1.6M |
| Q1 2025 | Apr 30, 2025 | −$0.23 | −$0.21 | 7.18% | $379,206.62 | $1.1M |
| Q4 2024 | Mar 13, 2025 | −$0.20 | −$0.18 | 14.55% | $819,453.47 | $1.3M |
| Q3 2024 | Nov 5, 2024 | −$0.16 | $0.06 | 136.62% | $8.6M | $30.1M |
| Q2 2024 | Aug 6, 2024 | $0.53 | −$0.26 | -148.37% | $101.0M | $764,150.10 |
| Q1 2024 | May 13, 2024 | −$0.15 | −$0.20 | -33.18% | $5.9M | — |
| Q4 2023 | Mar 14, 2024 | −$0.11 | −$0.06 | 47.53% | $17.9M | $17.6M |
| Q3 2023 | Nov 3, 2023 | $0.03 | −$0.20 | -695.76% | $54.6M | — |
| Q2 2023 | Aug 4, 2023 | −$0.22 | −$0.22 | -2.81% | $2.8M | — |
| Q1 2023 | Apr 28, 2023 | −$0.25 | −$0.23 | 9.33% | — | — |
| Q4 2022 | Mar 16, 2023 | −$0.27 | −$0.24 | 11.79% | $1.7M | — |
| Q3 2022 | Oct 28, 2022 | −$0.23 | −$0.16 | 32.63% | $354,375.00 | $4.0M |
| Q2 2022 | Jul 28, 2022 | −$0.25 | −$0.23 | 5.21% | — | — |
| Q1 2022 | Apr 28, 2022 | −$0.24 | −$0.24 | 0.33% | $379,050.00 | — |
| Q4 2021 | Mar 22, 2022 | $0.11 | −$0.27 | -346.62% | $30.8M | — |
| Q3 2021 | Nov 8, 2021 | −$0.29 | −$0.22 | 25.23% | $679,002.64 | — |
| Q2 2021 | Aug 4, 2021 | −$0.23 | −$0.28 | -24.03% | $1.9M | $162,276.19 |
| Q1 2021 | Apr 28, 2021 | −$0.24 | −$0.24 | 0.20% | $3.6M | — |

## Frequently Asked Questions

### When did AC Immune (ACIU) last report earnings?

AC Immune last reported on Mar 13, 2026, covering fiscal Q4 2025.

### Did ACIU beat earnings estimates?

Yes. AC Immune reported EPS of −$0.18 for Q4 2025 against a −$0.21 estimate — a 16.22% beat.

### How much revenue did ACIU report last quarter?

AC Immune reported $428,876.00 in revenue for Q4 2025, against a consensus estimate of $1.4M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).